All of WSIPP's research is published on our website. The Publications page includes every report we've released—from our founding in 1983 to the present. Each report entry includes the title, publication date, abstract, any available supplemental materials, and a downloadable PDF.
WSIPP reports are not updated after publication, and any report older than two years is designated with an “Archived” label.
To explore our benefit-cost and meta-analytic findings, please visit the Benefit-Cost section of the website.
Use the search fields below to find specific publications that match certain criteria. If you want to find other information on our website that is not publications, you can use the search field in the navigation bar at the top, or click here to search the entire website.
Found 1 results
The 2015 Washington State Legislature directed WSIPP to review existing literature and begin a four-year study to evaluate outcomes regarding the cost-effectiveness of FDA-approved long-acting injectable medications, focusing on the benefits to persons in prison when they are released into the community.
We review the research evidence on the effectiveness of these medications in reducing substance abuse and recidivism rates. Where possible, we calculate whether the benefits of administering long-acting injectable medications outweigh the costs.